Table 3.
Recommendations for all patients taking urate-lowering therapy (ULT)*
| Recommendation | PICO question | Certainty of evidence |
|---|---|---|
| For all patients taking ULT, we strongly recommend a treat-to-target strategy of ULT dose management that includes dose titration and subsequent dosing guided by serial SU values to achieve an SU target over a fixed, standard-dose ULT strategy. | 13 | Moderate |
| For all patients taking ULT, we strongly recommend continuing ULT to achieve and maintain an SU target of <6 mg/dl over no target. | 14 | High |
| For all patients taking ULT, we conditionally recommend delivery of an augmented protocol of ULT dose management by nonphysician providers to optimize the treat-to-target strategy that includes patient education, shared decision-making, and treat-to-target protocol. | 8 | Moderate |
| We conditionally recommend continuing ULT indefinitely over stopping ULT. | 19 | Very low |
|
| ||
| Strongly recommend Conditionally recommend Strongly recommend against Conditionally recommend against | ||
PICO = population, intervention, comparator, outcomes; SU = serum urate.